We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.46%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$81.2B
AUM Growth
+$4.94B
(+6.5%)
Cap. Flow
-$6.14B
Cap. Flow
% of AUM
-7.55%
Top 10 Holdings %
Top 10 Hldgs %
23.23%
Holding
2,627
New
307
Increased
786
Reduced
648
Closed
292
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$410M |
| 2 |
American Electric Power
AEP
|
+$309M |
| 3 |
UnitedHealth
UNH
|
+$239M |
| 4 |
Johnson & Johnson
JNJ
|
+$235M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$330M |
| 2 |
Consolidated Edison
ED
|
+$330M |
| 3 |
PNC Financial Services
PNC
|
+$284M |
| 4 |
Salesforce
CRM
|
+$173M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.56% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 13.3% |
| 4 | Industrials | 12.02% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Cartesian Therapeutics
RNAC
$231M
| $12K | ﹤0.01% |
373
+8
| +2% | +$286 |
|
1952
Banco Santander
SAN
$206B
| $12K | ﹤0.01% |
3,291
+348
| +12% | +$1.23K |
|
|
EBTC
1953
DELISTED
Enterprise Bancorp
EBTC
| $11K | ﹤0.01% |
381
| – | – |
|
1954
Lineage Cell Therapeutics
LCTX
$277M
| $11K | ﹤0.01% |
8,380
+314
| +4% | +$434 |
|
1955
Solid Biosciences
SLDB
$790M
| $11K | ﹤0.01% |
2,216
+127
| +6% | +$715 |
|
1956
VSE Corp
VSEC
$5.81B
| $11K | ﹤0.01% |
209
-2,056
| -91% | -$99.4K |
|
1957
Xperi
XPER
$377M
| $11K | ﹤0.01% |
853
| – | – |
|
1958
Atara Biotherapeutics
ATRA
$77M
| $10K | ﹤0.01% |
271
+99
| +58% | +$5.6K |
|
1959
BHP
BHP
$212B
| $10K | ﹤0.01% |
168
+44
| +35% | +$2.62K |
|
1960
Conagra Brands
CAG
$7.14B
| $10K | ﹤0.01% |
325
-33
| -9% | -$1.19K |
|
|
DRD
1961
DRDGold
DRD
$1.81B
| $10K | ﹤0.01% |
+996
| New | +$11.3K |
|
1962
Tango Therapeutics
TNGX
$4.43B
| $10K | ﹤0.01% |
3,341
+97
| +3% | +$349 |
|
|
GRTS
1963
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $10K | ﹤0.01% |
5,631
+149
| +3% | +$349 |
|
1964
Barclays
BCS
$93.8B
| $9K | ﹤0.01% |
1,204
-1,097
| -48% | -$8.49K |
|
1965
CorVel
CRVL
$3.09B
| $9K | ﹤0.01% |
147
-1,050
| -88% | -$70.3K |
|
1966
DT Midstream
DTM
$13.8B
| $9K | ﹤0.01% |
185
| – | – |
|
1967
CGI
GIB
$15.1B
| $9K | ﹤0.01% |
+88
| New | +$8.96K |
|
1968
ProQR Therapeutics
PRQR
$241M
| $9K | ﹤0.01% |
5,912
+155
| +3% | +$303 |
|
|
OMGA
1969
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $9K | ﹤0.01% |
1,714
+72
| +4% | +$563 |
|
|
CHUY
1970
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $9K | ﹤0.01% |
228
-1,420
| -86% | -$52.9K |
|
|
AFMD
1971
DELISTED
Affimed
AFMD
| $8K | ﹤0.01% |
1,427
+9
| +0.6% | +$72 |
|
1972
Repligen
RGEN
$8.3B
| $8K | ﹤0.01% |
65
-430
| -87% | -$68.9K |
|
1973
Rentokil
RTO
$12B
| $8K | ﹤0.01% |
212
| – | – |
|
1974
ArcelorMittal
MT
$54.2B
| $7K | ﹤0.01% |
280
| – | – |
|
1975
Patrick Industries
PATK
$2.77B
| $7K | ﹤0.01% |
146
-4,219
| -97% | -$199K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Lazard Asset Management held 2,627 positions worth $81.2B, up 6.5% from $76.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $6.14B in Q2 2023, closing 292 positions and reducing 648 holdings. Its most notable exit was ABB Ltd, an estimated $107M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Nice worth $14.7M.
- Lazard Asset Management's largest Q2 2023 buy was Nice: 71,266 shares worth $14.7M.
- Lazard Asset Management added most to Exelon in Q2 2023, an estimated $410M increase.
- Lazard Asset Management's biggest Q2 2023 reduction was Dollar General, cutting an estimated $330M.
- Lazard Asset Management fully exited ABB Ltd in Q2 2023, selling an estimated $107M.
- Lazard Asset Management's ten largest holdings make up 23% of its $81.2B portfolio in Q2 2023.
- Lazard Asset Management opened 307 new positions and closed 292 in Q2 2023.
- Lazard Asset Management's portfolio value rose 6.5% quarter-over-quarter to $81.2B.
Based on Lazard Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.